Web18 sep. 2024 · Dr Reddy's Labs rallied 14 per cent to hit an intra-day high of Rs 5,497 on the BSE Dr Reddy's Laboratories reclaimed the tag of being the second most valuable … Web30 mrt. 2024 · India’s domestic pharmaceutical market stood at US$ 42 billion in 2024 and is likely to reach US$ 65 billion by 2024 and further expand to reach US$ 120-130 billion by 2030. Indian drug & pharmaceutical exports stood at US$ ... Dr. Reddy's Laboratories: 1984: Dr. Kallam Anji Reddy: Hyderabad: $9.1 Billion: $2.7 ... Share this post ...
Dr. Reddy
Web28 jul. 2024 · View the real-time Dr. Reddy's Labs (NS REDY) share price and assess historical data, charts, technical analysis and the share chat forum. Download the App … Web9 mrt. 2024 · Dr Reddy's, India's fourth-biggest pharmaceutical company by market value, sells pain killers and other medicines in Russia. It is the main distributor in India for Russia's Sputnik COVID-19 vaccines. china emerging markets report
Dr Reddys Laboratories Market Capital - Business Standard
Web13 apr. 2024 · Market Average Movement. 5.6%. 10% most volatile stocks in IN Market. 9.0%. 10% least volatile stocks in IN Market. 3.4%. Stable Share Price: 500124 is less volatile than 75% of Indian stocks over the past 3 months, typically moving +/- 2% a week. Volatility Over Time: 500124's weekly volatility (2%) has been stable over the past year. Web28 okt. 2024 · Dr. Reddy’s profit jumps 12% YoY to Rs. 1,114 crore; Revenue rises over 9% The Financial Express. North America contributed the most to the overall sales of Dr … Web29 mrt. 2024 · Dr. Reddy's Laboratories is an Indian ... revenues by 2:1 factor in 2002 • US continued to be the biggest pharma market accounting $245 B of $500 B global market • India provided an advantage ... 2006 • Betapharm had 3.5% market share • Betapharm’s mfg would shift to India since DRL’s facilities were already European ... graft patency cabg